Finomel Peri emulsion for infusion
*Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
Alanine Arginine Calcium Chloride Dihydrate Glucose Monohydrate Glycine Histidine Isoleucine Leucine Lysine Hydrochloride Methionine Phenylalanine Potassium Chloride Proline Refined Olive Oil Refined Soybean Oil Serine Sodium Acetate, Trihydrate Sodium Glycerophosphate, hydrated Threonine Tryptophan Tyrosine Valine Zinc Sulfate Heptahydrate Magnesium Sulfate Heptahydrate Fish Oil, rich in Omega-3-Acids Medium-Chain Triglycerides *Additional information is available within the SPC or upon request to the company
Updated on 17 January 2024
File name
ie_spc_Finomel Peri_PA2299-044-001_January 2024.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 09 August 2023
File name
ie-mockup-pl-finomelperi.pdf
Reasons for updating
- New PIL for new product
Updated on 23 January 2023
File name
ie-spc-finomelperi.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 August 2019
File name
ie-spc-finomelperi.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)